BeOne Medicines (BEIGF) Net Income towards Common Stockholders Growth (3y) (2018 - 2026)
BeOne Medicines (BEIGF) Net Income towards Common Stockholders Growth (3y) (2018 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Net Income Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
821,726.73 Bn |
821,726.69 Bn |
- |
- |
| 2 |
Belite Bio |
57,768.00 Bn |
57,768.00 Bn |
- |
84.25% |
| 3 |
Quantum Biopharma |
16,655.88 Bn |
16,655.88 Bn |
- |
-10.84% |
| 4 |
Legend Biotech |
3,540.00 Bn |
3,539.71 Bn |
242.10 Mn |
26.38% |
| 5 |
Evaxion A |
1,526.26 Bn |
1,526.24 Bn |
- |
34.98% |
| 6 |
Akari Therapeutics |
1,520.09 Bn |
1,520.09 Bn |
- |
-46.86% |
| 7 |
Psyence Biomedical |
223.87 Bn |
223.87 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
114.47 Bn |
107.23 Bn |
2.59 Bn |
13.80% |
| 9 |
Abivax |
91.22 Bn |
91.22 Bn |
- |
- |
| 10 |
BeOne Medicines |
- |
- |
1.35 Bn |
38.43% |
| Date | Value |
|---|
| Mar 31, 2026 |
38.43% |
| Dec 31, 2025 |
29.05% |
| Sep 30, 2025 |
30.53% |
| Jun 30, 2025 |
29.40% |
| Mar 31, 2025 |
26.05% |
| Dec 31, 2024 |
36.41% |
| Sep 30, 2024 |
34.81% |
| Jun 30, 2024 |
36.95% |
| Mar 31, 2024 |
-79.43% |
| Dec 31, 2023 |
9.79% |
| Sep 30, 2023 |
35.62% |
| Jun 30, 2023 |
-3.23% |
| Mar 31, 2023 |
2.83% |
| Dec 31, 2022 |
-3.30% |
| Sep 30, 2022 |
-19.78% |
| Jun 30, 2022 |
-76.24% |
| Mar 31, 2022 |
-33.73% |
| Dec 31, 2021 |
-28.08% |
| Sep 30, 2021 |
-40.64% |
| Jun 30, 2021 |
-45.21% |
